Want to see IDXG full AI Analyst Report?
Interpace Diagnostics Group (IDXG) Ratios
Interpace Diagnostics Group Ratios
IDXG's free cash flow for Q2 2026 was $41.00K. For the 2026 fiscal year, IDXG's free cash flow was decreased by $-57.00K and operating cash flow was $98.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.94 | 1.11 | 0.59 | 0.85 | 0.78 |
| Quick Ratio | 1.72 | 1.00 | 0.52 | 0.77 | 0.66 |
| Cash Ratio | 0.49 | 0.14 | 0.20 | 0.34 | 0.21 |
| Solvency Ratio | 2.21 | 0.44 | 0.06 | -0.04 | -0.12 |
| Operating Cash Flow Ratio | 1.14 | 0.44 | 0.22 | -0.54 | -0.56 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 1.08 | 0.74 | -3.08 | 0.00 |
| Net Current Asset Value | $ -1.57M | $ -5.24M | $ -17.84M | $ -66.90M | $ -68.68M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.40 | 0.86 | 1.01 | 0.36 |
| Debt-to-Equity Ratio | 0.05 | -2.64 | -0.74 | -0.26 | -0.32 |
| Debt-to-Capital Ratio | 0.05 | 1.61 | -2.84 | -0.34 | -0.48 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.39 | -0.22 | -0.29 |
| Financial Leverage Ratio | 1.51 | -6.67 | -0.86 | -0.25 | -0.91 |
| Debt Service Coverage Ratio | 154.60 | 1.69 | 0.63 | -0.65 | -0.64 |
| Interest Coverage Ratio | 24.31 | 12.30 | 2.78 | -3.81 | -11.29 |
| Debt to Market Cap | 0.00 | 0.36 | 2.00 | 3.10 | 0.31 |
| Interest Debt Per Share | 1.53 | 1.49 | 2.83 | 4.03 | 3.57 |
| Net Debt to EBITDA | -0.28 | 0.53 | 2.01 | -4.97 | -7.83 |
| Profitability Margins | |||||
| Gross Profit Margin | 62.31% | 63.77% | 59.44% | 57.26% | 43.44% |
| EBIT Margin | 10.18% | 16.21% | 6.99% | -15.16% | -16.22% |
| EBITDA Margin | 12.30% | 17.81% | 9.54% | -7.12% | -3.21% |
| Operating Profit Margin | 10.55% | 17.28% | 6.97% | -12.06% | -28.41% |
| Pretax Profit Margin | 9.74% | 14.81% | 2.81% | -18.33% | -37.31% |
| Net Profit Margin | 63.46% | 14.28% | 1.99% | -18.42% | -35.69% |
| Continuous Operations Profit Margin | 64.51% | 14.80% | 2.77% | -18.42% | -17.03% |
| Net Income Per EBT | 651.17% | 96.43% | 71.04% | 100.50% | 95.67% |
| EBT Per EBIT | 92.41% | 85.72% | 40.26% | 151.98% | 131.32% |
| Return on Assets (ROA) | 72.63% | 45.31% | 6.16% | -36.70% | -38.37% |
| Return on Equity (ROE) | 109.89% | -302.30% | -5.30% | 9.30% | 34.76% |
| Return on Capital Employed (ROCE) | 14.21% | 194.11% | -62.97% | -226.42% | -51.60% |
| Return on Invested Capital (ROIC) | 14.00% | 91.56% | 269.70% | -80.44% | -47.77% |
| Return on Tangible Assets | 72.63% | 45.31% | 6.16% | -38.79% | -64.94% |
| Earnings Yield | 451.62% | 56.58% | 17.20% | -133.07% | -47.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.86 | 5.49 | 8.07 | 6.33 | 8.84 |
| Payables Turnover | 14.85 | 10.25 | 10.56 | 12.96 | 17.01 |
| Inventory Turnover | 13.10 | 14.04 | 13.29 | 11.12 | 13.08 |
| Fixed Asset Turnover | 14.67 | 15.78 | 15.15 | 10.91 | 3.98 |
| Asset Turnover | 1.14 | 3.17 | 3.09 | 1.99 | 1.08 |
| Working Capital Turnover Ratio | 13.01 | -15.66 | -8.67 | -11.28 | -10.83 |
| Cash Conversion Cycle | 56.52 | 56.84 | 38.13 | 62.36 | 47.71 |
| Days of Sales Outstanding | 53.24 | 66.46 | 45.23 | 57.69 | 41.28 |
| Days of Inventory Outstanding | 27.85 | 26.00 | 27.46 | 32.83 | 27.90 |
| Days of Payables Outstanding | 24.58 | 35.62 | 34.55 | 28.17 | 21.46 |
| Operating Cycle | 81.09 | 92.46 | 72.69 | 90.52 | 69.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.59 | 1.06 | 0.88 | -1.82 | -2.11 |
| Free Cash Flow Per Share | 6.19 | 0.86 | 0.77 | -1.89 | -2.19 |
| Dividend Paid and CapEx Coverage Ratio | 16.38 | 5.30 | 8.06 | -23.89 | -24.63 |
| Capital Expenditure Coverage Ratio | 16.38 | 5.30 | 8.06 | -23.89 | -24.63 |
| Operating Cash Flow Coverage Ratio | 4.93 | 0.79 | 0.34 | -0.48 | -0.64 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.10 | 0.09 | -0.24 | -0.21 |
| Free Cash Flow Yield | 100.62% | 31.83% | 71.19% | -181.83% | -29.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 0.22 | 1.90 | 5.81 | -0.75 | -2.09 |
| Price-to-Sales (P/S) Ratio | 0.14 | 0.25 | 0.12 | 0.14 | 0.75 |
| Price-to-Book (P/B) Ratio | 0.24 | -5.34 | -0.31 | -0.07 | -0.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.99 | 3.14 | 1.40 | -0.55 | -3.40 |
| Price-to-Operating Cash Flow Ratio | 0.93 | 2.55 | 1.23 | -0.57 | -3.54 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | -0.05 | 0.01 | 0.05 |
| Enterprise Value Multiple | 0.86 | 1.94 | 3.22 | -6.91 | -31.09 |
| Enterprise Value | 4.12M | 16.24M | 12.36M | 15.67M | 41.29M |
| EV to EBITDA | 0.86 | 1.94 | 3.22 | -6.91 | -31.09 |
| EV to Sales | 0.11 | 0.35 | 0.31 | 0.49 | 1.00 |
| EV to Free Cash Flow | 0.75 | 4.31 | 3.72 | -1.96 | -4.55 |
| EV to Operating Cash Flow | 0.71 | 3.50 | 3.26 | -2.04 | -4.74 |
| Tangible Book Value Per Share | 25.27 | -0.51 | -3.51 | -15.09 | -14.06 |
| Shareholders’ Equity Per Share | 25.27 | -0.51 | -3.51 | -14.88 | -10.26 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -5.62 | 0.00 | 0.02 | -0.00 | 0.04 |
| Revenue Per Share | 43.77 | 10.70 | 9.32 | 7.51 | 9.99 |
| Net Income Per Share | 27.77 | 1.53 | 0.19 | -1.38 | -3.57 |
| Tax Burden | 6.51 | 0.96 | 0.71 | 1.00 | 0.96 |
| Interest Burden | 0.96 | 0.91 | 0.40 | 1.21 | 2.30 |
| Research & Development to Revenue | 0.02 | 0.01 | 0.02 | 0.02 | 0.05 |
| SG&A to Revenue | 0.50 | 0.45 | 0.23 | 0.34 | 0.33 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.02 | 0.04 | 0.03 |
| Income Quality | 0.24 | 0.69 | 4.72 | 0.35 | 0.58 |
Currency in USD